Development Level

Tclin 4 | 613
Tchem 3 | 1,598
Tbio 1 | 11,445

IMPC Phenotype

decreased CD4-positive, alpha ... 1 | 7
decreased CD8-positive, alpha-... 1 | 8
decreased T cell number 1 | 15
increased IgG2b level 1 | 1
increased mean corpuscular vol... 1 | 92

Disease

Carcinoma 7 | 11,493
psoriasis 5 | 6,694
Depressive disorder 4 | 409
Schizophrenia 4 | 1,160
medulloblastoma, large-cell 4 | 6,241
Alcoholic Intoxication, Chronic 3 | 289
Autistic Disorder 3 | 364
Breast cancer 3 | 3,578
Hypertension 3 | 396
Mental Depression 3 | 333
breast carcinoma 3 | 1,638
ductal carcinoma in situ 3 | 1,745
malignant mesothelioma 3 | 3,232
osteosarcoma 3 | 7,950
Alcoholism 2 | 45
Alexithymia 2 | 16
Anxiety disorder 2 | 23
Asperger syndrome 2 | 37
Asthma 2 | 385
Attention deficit hyperactivity disorder 2 | 278
Autosomal recessive predisposition 2 | 1,442
Borderline personality disorder 2 | 11
Bronchial Diseases 2 | 3
Cancer 2 | 2,499
Epilepsy 2 | 792
Hypertensive disease 2 | 292
Irritable bowel syndrome 2 | 60
Kidney cancer 2 | 2,613
Major Depressive Disorder 2 | 301
Mood Disorders 2 | 184
Pain agnosia 2 | 104
Postpartum depression 2 | 8
Prader-Willi syndrome 2 | 48
Retinitis Pigmentosa 2 | 226
Seizures 2 | 596
Unipolar Depression 2 | 250
atypical teratoid / rhabdoid tumor 2 | 5,112
chronic rhinosinusitis 2 | 512
colon cancer 2 | 1,478
fibroadenoma 2 | 559
glioblastoma 2 | 5,792
group 4 medulloblastoma 2 | 1,855
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
nasopharyngeal carcinoma 2 | 1,058
ovarian cancer 2 | 8,520
pancreatic cancer 2 | 2,398
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
primitive neuroectodermal tumor 2 | 3,035
Acute exacerbation of asthma 1 | 14
Allergic Reactions 1 | 7
Anosmia 1 | 22
Asphyxia neonatorum 1 | 11
Asthma management 1 | 19
Atypical autism 1 | 26
Chorioamnionitis 1 | 14
Complex regional pain syndrome 1 | 12
Conscious sedation 1 | 10
Cystitis 1 | 15
Dermal Necrosis 1 | 6
Diabetes insipidus 1 | 18
Diagnostic Test for Pheochromocytoma 1 | 6
Dysmenorrhea 1 | 21
Endometritis 1 | 21
Epilepsy, Tonic-Clonic 1 | 10
Exacerbation of asthma 1 | 11
Genetic Predisposition to Disease 1 | 27
Hypertension Secondary to Pheochromocytoma 1 | 6
Hypoactive sexual desire disorder 1 | 8
Hypogonadotropic Hypogonadism 7 With or Without Anosmia 1 | 6
Hyponatremia 1 | 25
Inhibited male orgasm 1 | 1
Kallmann syndrome 1 | 33
Low blood pressure 1 | 9
Meconium aspiration syndrome 1 | 4
Motion sickness 1 | 21
Myoma 1 | 12
Nasal discharge 1 | 24
Neurogenic Inflammation 1 | 12
Neurohypophyseal diabetes insipidus 1 | 13
Orthostatic hypotension 1 | 9
Paroxysmal hypertension 1 | 6
Placenta accreta 1 | 5
Placenta praevia 1 | 8
Prevention of Cerebral Thrombosis 1 | 29
Prevention of Hypertension in Pheochromocytoma 1 | 6
Psychomotor Disorders 1 | 7
Red eye 1 | 7
Reflex, Abnormal 1 | 5
Retinitis pigmentosa 67 1 | 5
Rosacea 1 | 25
Seizures, Focal 1 | 14
Sexual dysfunction 1 | 9
Sjögren's syndrome 1 | 5
Spasm 1 | 6
Telogen effluvium 1 | 4
Tremor of hands 1 | 3
Uterine inversion 1 | 5
Wheezing 1 | 7
anaphylaxis 1 | 11

Tissue

Endocrine System 8 | 18,159
Female tissues 8 | 17,400
Nervous System 8 | 16,725
Respiratory system 8 | 16,393
Urinary Tract 8 | 16,678
Blood and immune system 7 | 16,909
Digestive Tract 7 | 17,369
Liver and Pancreas 7 | 16,750
Male tissues 7 | 17,142
Skin and soft tissues 7 | 17,230
Cardiovascular System 5 | 15,192

Target Family

GPCR 6 | 408
Enzyme 1 | 4,145
Non-IDG 1 | 12,091

GO Process

positive regulation of uterine... 8 | 8
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Alpha-2B adrenergic receptor ADRA2B Tclin GPCR -2.15839 139.8 0
G-protein coupled estrogen receptor 1 GPER1 Tchem GPCR -2.78141 706.4 288
Oxytocin receptor OXTR Tclin GPCR -2.90022 820.8 255
Substance-P receptor TACR1 Tclin GPCR -3.10271 1238.0 435
Oxytocin-neurophysin 1 OXT Tbio Non-IDG -4.19199 15349.6 152
4-aminobutyrate aminotransferase, mitochondrial ABAT Tclin Enzyme -2.02391 104.3 204
Neuromedin-K receptor TACR3 Tchem GPCR -2.37706 221.7 261
Substance-K receptor TACR2 Tchem GPCR -2.56577 318.3 189